Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients.
An early British case of neuromyelitis optica (1850).
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Sleep-disordered breathing in multiple sclerosis.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Regulation: The FDA is overcautious on consumer genomics.
Novartis: CHMP Issues Positive Opinion To Expand EU Label For Gilenya In RRMS
Are there evidence-based dietary interventions for multiple sclerosis?
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Coexistence of Guillain-Barré syndrome and Behçet's disease.
Natalizumab-Induced Progressive Multifocal Leukoencephalopathy.
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis.
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Pages